These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 735881)
1. The effect of the converting enzyme inhibitor SQ 20.881 on kinins, renin-angiotensin-aldosterone and catecholamines in relation to blood pressure in hypertensive patients. Hulthén L; Hökfelt B Acta Med Scand; 1978; 204(6):497-502. PubMed ID: 735881 [TBL] [Abstract][Full Text] [Related]
2. Differences in response to the peptidyldipeptide hydrolase inhibitors SQ 20,881 and SQ 14,225 in normal-renin essential hypertension. Crantz FR; Swartz SL; Hollenberg NK; Moore TJ; Dluhy RG; Williams GH Hypertension; 1980; 2(5):604-9. PubMed ID: 6158478 [TBL] [Abstract][Full Text] [Related]
3. [The acute effects of the new angiotensin I-converting enzyme inhibitor, enalapril maleate, on blood pressure, plasma renin, aldosterone and kinins in hypertensive patients]. Gotoh M; Mizuno K; Hashimoto S; Kunii N; Fukuchi S Nihon Naibunpi Gakkai Zasshi; 1985 May; 61(5):619-29. PubMed ID: 2991035 [TBL] [Abstract][Full Text] [Related]
4. Effect of angiotensin converting enzyme inhibition on blood pressure, plasma renin activity and plasma aldosterone in essential hypertension. Gavras H; Gavras I; Textor S; Volicer L; Brunner HR; Rucinska EJ J Clin Endocrinol Metab; 1978 Feb; 46(2):220-6. PubMed ID: 220274 [No Abstract] [Full Text] [Related]
5. Hormonal and blood pressure changes during converting enzyme inhibition by teprotide. VandenBurg MJ; Sharman VL; Morton JJ; Williams GH; Marsh FP Postgrad Med J; 1981 May; 57(667):283-8. PubMed ID: 6170971 [TBL] [Abstract][Full Text] [Related]
6. Effects of angiotensin I converting enzyme inhibitor (SQ 14,225) on the responses of blood pressure and steroid hormone to angiotensin II and ACTH infusion in hypertensive subjects. Ueda Y; Honda M; Hatano M Jpn Circ J; 1982 Mar; 46(3):267-73. PubMed ID: 6278173 [TBL] [Abstract][Full Text] [Related]
7. The effect of captopril on catecholamines, renin activity, angiotensin II and aldosterone in plasma during physical exercise in hypertensive patients. Manhem P; Bramnert M; Hulthén UL; Hökfelt B Eur J Clin Invest; 1981 Oct; 11(5):389-95. PubMed ID: 6800810 [TBL] [Abstract][Full Text] [Related]
8. Role of the renin-angiotensin system in the regulation of aldosterone biosynthesis and arterial pressure during sodium deficiency. McCaa RE Circ Res; 1977 May; 40(5 Suppl 1):I157-62. PubMed ID: 870226 [TBL] [Abstract][Full Text] [Related]
9. The role of the renin-angiotensin-aldosterone system in cardiovascular homeostasis in normal human subjects. Sancho J; Re R; Burton J; Barger AC; Haber E Circulation; 1976 Mar; 53(3):400-5. PubMed ID: 174834 [TBL] [Abstract][Full Text] [Related]
10. Beta-adrenergic receptor blockade as a therapeutic approach for suppressing the renin-angiotensin-aldosterone system in normotensive and hypertensive subjects. Blumenfeld JD; Sealey JE; Mann SJ; Bragat A; Marion R; Pecker MS; Sotelo J; August P; Pickering TG; Laragh JH Am J Hypertens; 1999 May; 12(5):451-9. PubMed ID: 10342782 [TBL] [Abstract][Full Text] [Related]
11. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems. Ohman KP; Karlberg BE; Nilsson OR; Wettre S Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190 [TBL] [Abstract][Full Text] [Related]
12. The use of angiotensin-converting enzyme inhibitor in the diagnosis and treatment of hypertension. Gavras H; Brunner HR; Laragh JH; Gavras I; Vukovich RA Clin Sci Mol Med Suppl; 1975 Jun; 2():57s-60s. PubMed ID: 1077792 [TBL] [Abstract][Full Text] [Related]
13. Treatment of patients with severe hypertension by inhibition of angiotensin-converting enzyme. Johnson JG; Black WD; Vukovich RA; Hatch FE; Friedman BI; Blackwell CF; Shenouda AN; Share L; Shade RE; Acchiardo SR; Muirhead EE Clin Sci Mol Med Suppl; 1975 Jun; 2():53s-56s. PubMed ID: 1077791 [TBL] [Abstract][Full Text] [Related]
14. Response of the kallikrein-kinin and renin-angiotensin systems to saline infusion and upright posture. Wong PY; Talamo RC; Williams GH; Colman RW J Clin Invest; 1975 Apr; 55(4):691-8. PubMed ID: 235559 [TBL] [Abstract][Full Text] [Related]
15. Nisoldipine--effects on the renin-angiotensin-aldosterone system and catecholamines. Studies in normotensive and hypertensive subjects. Ottosson AM; Karlberg BE J Intern Med; 1990 Nov; 228(5):503-9. PubMed ID: 2254722 [TBL] [Abstract][Full Text] [Related]
17. The effect of converting enzyme inhibition with SQ20,881 on plasma and urinary kinins, prostaglandin E, and angiotensin II in hypertensive man. Vinci JM; Horwitz D; Zusman RM; Pisano JJ; Catt KJ; Keiser HR Hypertension; 1979; 1(4):416-26. PubMed ID: 232086 [No Abstract] [Full Text] [Related]
18. Effects of prolonged and brief infusions of noradrenaline on arterial pressure and on the plasma concentrations of active renin, angiotensin II, aldosterone and potassium. Casals-Stenzel J; Tree M; Brown JJ; Fraser R; Lever AF; Millar JA; Morton JJ; Robertson JI; Reid JL; Hamilton C J Hypertens; 1983 Jun; 1(1):27-35. PubMed ID: 6397510 [TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme inhibitor (SQ 20881) in the diagnosis of renovascular hypertension. Rosenthal T; Kissin E; Jacob ET; Stern N; Levi Y; Adar R Angiology; 1979 Feb; 30(2):123-8. PubMed ID: 434566 [TBL] [Abstract][Full Text] [Related]
20. Effects of short-term norepinephrine infusion on plasma catecholamines, renin, and aldosterone in normal and hypertensive man. Beretta-Piccoli C; Weidmann P; Meier A; Grimm M; Keusch G; Glück Z Hypertension; 1980; 2(5):623-30. PubMed ID: 6998868 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]